Craven Street Capital advises Rutherford Health on £55m development framework agreement with Equitix

23 June 2020

We are delighted to announce that Craven Street Capital has advised Rutherford Health and Rutherford Diagnostics on the establishment of a £55m development framework agreement with the infrastructure investor Equitix. We set out the announcement below.

Craven Street Capital advised Rutherford Health on a £30m debt facility in 2016 and is pleased to continue to work with this innovative client.

Craven Street Capital advises on acquisitions, disposals, IPOs, debt and equity in the mid market. We are focussed on financial services, but also act for selected clients in healthcare, cleantech and infrastructure.

We continue to be highly active during this period of lockdown and would be pleased to discuss how we could assist you.

For more information: https://www.nexexchange.com/announcements?newsid=4674977